Literature DB >> 17306576

Functional, inflammatory and morphological characterisation of a cat model of allergic airway inflammation.

Nathalie Kirschvink1, Jérôme Leemans, François Delvaux, Frédéric Snaps, Cécile Clercx, Pascal Gustin.   

Abstract

The aims of this study were to characterise a model of feline allergic airway inflammation and to test through a longitudinal investigation whether five repeated allergen exposures would lead to signs of airway remodelling that would be detectable in vivo. Eight healthy control cats and eight cats sensitised with Ascaris suum allergens were investigated. Barometric whole body plethysmography (BWBP) was used for the assessment of respiratory variables and airway responsiveness (AR). Bronchoalveolar lavage fluid (BALF) was sampled for cytology and determination of F(2)-isoprostane concentration and matrix metalloproteinase type 9 (MMP-9) activity. Thoracic radiography and bronchoscopy scores were also established. Cats were investigated prior to sensitisation and after inhalation of placebo or allergen challenge 1. BWBP measurements revealed a significant increase of enhanced pause (Penh), an index of bronchoconstriction, and AR in sensitised cats in response to allergen challenge 1. A significant increase in BALF neutrophil and eosinophil %, F(2)-isoprostane concentration and MMP-9 activity, and increased radiography and bronchoscopy scores were recorded. After a recovery period of 6 weeks, all variables except BALF MMP-9 returned to baseline values. Four further allergen challenges induced similar changes to those seen in challenge 1 and no signs of persistent changes suggestive of bronchial remodelling were detectable. The model provides an in vivo approach to functional, inflammatory and morphological changes occurring in response to single and repeated allergen exposure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306576     DOI: 10.1016/j.tvjl.2006.11.004

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  8 in total

1.  Treatment of naturally occurring asthma with inhaled fluticasone or oral prednisolone: A randomized pilot trial.

Authors:  Michael Verschoor-Kirss; Elizabeth A Rozanski; Claire R Sharp; Trisha J Oura; Ashley Egan; Perry Bain; Joyce Knoll
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

2.  Pharmacokinetics of masitinib in cats.

Authors:  François Bellamy; Thomas Bader; Alain Moussy; Olivier Hermine
Journal:  Vet Res Commun       Date:  2009-12       Impact factor: 2.459

3.  Noninvasive Recognition and Biomarkers of Early Allergic Asthma in Cats Using Multivariate Statistical Analysis of NMR Spectra of Exhaled Breath Condensate.

Authors:  Yan G Fulcher; Martial Fotso; Chee-Hoon Chang; Hans Rindt; Carol R Reinero; Steven R Van Doren
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 4.  Airway remodeling in asthma: what really matters.

Authors:  Heinz Fehrenbach; Christina Wagner; Michael Wegmann
Journal:  Cell Tissue Res       Date:  2017-02-11       Impact factor: 5.249

Review 5.  Animal models of asthma: utility and limitations.

Authors:  Marcelo Vivolo Aun; Rafael Bonamichi-Santos; Fernanda Magalhães Arantes-Costa; Jorge Kalil; Pedro Giavina-Bianchi
Journal:  J Asthma Allergy       Date:  2017-11-07

6.  Clinical features and radiographic findings in cats with eosinophilic, neutrophilic, and mixed airway inflammation (2011-2018).

Authors:  Elizabeth A Lee; Lynelle R Johnson; Eric G Johnson; William Vernau
Journal:  J Vet Intern Med       Date:  2020-04-27       Impact factor: 3.333

7.  Serum immunoglobulin E responses to aeroallergens in cats with naturally occurring airway eosinophilia compared to unaffected control cats.

Authors:  Maggie C Buller; Lynelle R Johnson; Catherine A Outerbridge; William Vernau; Stephen D White
Journal:  J Vet Intern Med       Date:  2020-11-03       Impact factor: 3.333

8.  Clinicopathologic and radiographic features in 33 cats with aspiration and 26 cats with bronchopneumonia (2007-2017).

Authors:  Jonathan D Dear; William Vernau; Eric G Johnson; Sean E Hulsebosch; Lynelle R Johnson
Journal:  J Vet Intern Med       Date:  2020-12-14       Impact factor: 3.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.